Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares China Large-Cap ETF (FXI) vs Philip Morris International Inc. (PM) Price & Performance

iShares China Large-Cap ETFTrade
Philip Morris International Inc.Trade

Price performance (Past 24H)

Key statistics

iShares China Large-Cap ETF vs Philip Morris International Inc. — how do they compare? iShares China Large-Cap ETF trades at $33.94 (market cap $3.86B), while Philip Morris International Inc. trades at $199.65 (market cap $312.50B). The key difference: Philip Morris International Inc. is far larger — about 81× iShares China Large-Cap ETF's market cap, and Philip Morris International Inc. pays a 3.19% dividend while iShares China Large-Cap ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares China Large-Cap ETF for 149 Days and Philip Morris International Inc. for 85 Days on average.

FXIPM
Market Cap
$3.86B$312.50B
Volume
16,323,8375,517,172
52-Week High
$41.08$200.50
52-Week Low
$31.59$144.33
Typical Hold Time
149 Days85 Days
Sector
—Consumer Staples
Enterprise Value
—$355.62B
Dividend Yield
—3.19%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares China Large-Cap ETF

FXI, the iShares China Large-Cap ETF, trades at $33.42, down 1.04% with bearish technical signals from moving averages. The ETF faces headwinds from China's economic challenges and trade tensions, though it trades at a significant discount to U.S. equities with a P/E of 11.10 versus the S&P 500's 22.54. Recent geopolitical developments from the Trump-Xi summit and China's export dynamics create mixed sentiment.

The outlook remains cautious with technical indicators signaling selling pressure, while fundamental valuation appears attractive for risk-tolerant investors seeking China exposure. Key risks include ongoing U.S.-China tensions, China's industrial overcapacity, and weak domestic consumption that could limit upside potential despite the valuation discount.

Philip Morris International Inc.

Philip Morris International (PM) trades at $192.69, up 1.2% today, with a bullish technical signal and strong analyst support. Recent Q2 2026 EPS beat expectations at $2.20 vs. $2.05, and revenue growth accelerated to $40.65B in 2025. The company's smoke-free products now drive 42% of revenue, with ZYN and IQOS expansions fueling optimism. Cash flow remains robust, with 2026 operating cash flow projected at $14.3B, supporting dividend growth.

Outlook is positive given earnings momentum and smoke-free transition, but high debt ($42.17B long-term) and regulatory risks persist. The consensus price target of $212.17 implies ~10% upside, though valuation multiples are elevated versus peers. Key risks include FX volatility and slower adoption of next-gen products.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FXI
50% Buy50% Sell
Avg holding period · 149 Days
PM
10% Buy90% Sell
Avg holding period · 85 Days

Top news

Latest headlines on both assets

About iShares China Large-Cap ETF

The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index designed to measure the performance of the largest companies in the Chinese equity market that trade on the Stock Exchange of Hong Kong and are available to international investors. The fund is non-diversified.

Read more on FXI →

About Philip Morris International Inc.

Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.

Read more on PM →